Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-based Algorithm Development for Improved Diagnostics in the Intensive Care and Acute Stroke Setting Using Electroencephalography (SMART-EEG)

NCT07886957 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT07886957 Recruiting Observational 825 participants (estimated) Started 2026 1 site

Follow this trial by email Email me the PDF

Get the NCT07886957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Recruiting, started March 2026. Observational study, 825 participants (estimated). Lead sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Netherlands. Primary measures: Prognostic performance of a subhairline EEG-based AI algorithm for neurological outcome prediction...; Diagnostic accuracy of a subhairline EEG-based AI algorithm for detection of intracerebral hemorrhage.

How it compares

71 similar trials: same condition (Hemorrhagic Stroke) and phase

Enrollment

This trial
825
Middle half
100 to 1,000
Median
300
Trials with a value
70

Months from start to completion

This trial
24
Middle half
15.3 to 76.5
Median
27.5
Trials with a value
71

Sites

This trial
1
Middle half
1 to 2
Median
1
Trials with a value
64
Posted results or a linked paper 34% 24 of 71 similar trials; this trial: no

Registry record

As filed in ClinicalTrials.gov.

Title
AI-based Algorithm Development for Improved Diagnostics in the Intensive Care and Acute Stroke Setting Using Electroencephalography (SMART-EEG)
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Observational
Overall status
Recruiting
Start date
March 26, 2026
Completion date
March 26, 2028
Enrollment
825 (estimated)
Sites
1

Conditions

MeSH condition names; the registry's own terms follow.

Hemorrhagic Stroke, Subarachnoid Hemorrhage

Registry terms: hemorrhagic stroke, intracerebral, postanoxic coma, subarachnoid haemorrhage (sah)

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
All
Minimum age
18 Years
Healthy volunteers
No
Study type
Observational
Sites
1
Countries
Netherlands
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Arms

As registered; 3 arms.

Registered arms
Arm Type Interventions
Postanoxic coma (UC1)
Show registry wording

adults in postanoxic coma after cardiac arrest admitted to the ICU

Suspected stroke (UC2.1)
Show registry wording

adults with suspected or confirmed stroke presenting to the emergency department

Suspected SAH (UC2.2)
Show registry wording

adults with suspected or confirmed subarachnoid hemorrhage presenting to the emergency department

Primary endpoints

Registered primary outcome measures; 2 primary.

Registered primary endpoints
Measure Time frame
Prognostic performance of a subhairline EEG-based AI algorithm for neurological outcome prediction in postanoxic coma EEG at 24 hours after cardiac arrest; neurological outcome at hospital discharge (up to 3 months after CA)
Show registry wording

Performance of the AI algorithm, based on subhairline EEG recorded at 24 hours after cardiac arrest, in predicting poor neurological outcome. Poor outcome is defined as CPC 3-5 at hospital discharge. Performance is expressed as the area under the ROC curve (AUC), sensitivity, specificity, positive and negative predictive values, each with 95% confidence intervals. The optimal cut-off for poor outcome is defined as the highest sensitivity at a false positive rate of 0%.

Diagnostic accuracy of a subhairline EEG-based AI algorithm for detection of intracerebral hemorrhage EEG at presentation (within 24 hours of symptom onset); final diagnosis at hospital discharge (up to 3 months after presentation)
Show registry wording

Diagnostic accuracy of the AI algorithm, based on subhairline EEG and clinical symptoms, in detecting intracerebral hemorrhage (ICH) in patients with suspected stroke. The reference standard is the final diagnosis based on neuroimaging. Accuracy is expressed as the area under the ROC curve (AUC), and as sensitivity, specificity, positive and negative predictive values at the optimal cut-off, each with 95% confidence intervals.

Lead sponsor's other trials

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), most recent start first.

Similar trials

Same condition (Hemorrhagic Stroke) and phase, most recent start first.